Notice of Intent to Sole Source - Rapid fFN Products - Hologic Sales and Services, LLC

HT941026Q2062

DEFENSE HEALTH AGENCY (DHA) → DEPT OF DEFENSE.DEFENSE HEALTH AGENCY (DHA).DEFENSE HEALTH AGENCY HCD WEST → DEFENSE HEALTH AGENCY HCD WEST

AI Summary

The Defense Health Agency (DHA) intends to award a sole source contract to Hologic Sales and Services, LLC for Rapid fFN (fetal fibronectin) products, a diagnostic medical supply used for assessing preterm birth risk, for a military medical facility in Guam. Interested parties must respond by August 28, 2026, to challenge the sole source decision. This is relevant to medical device distributors or manufacturers with experience supplying Hologic's Rapid fFN tests.

Key Requirements

• •No specific certifications are listed, but the notice indicates the government intends to sole source to Hologic, implying that potential challengers must demonstrate they can provide equivalent fFN products that meet the government's requirements.

Details

Point of Contact

Eddie L. “Franc” Franklin Jr.

Eddie.l.franklin.civ@health.mil

6713449643

Classification Code

6515